PAR-24-325-Full-Announcement.html

This document is a Funding Opportunity Announcement (FOA) for the "Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)" federal grant opportunity.

The FOA solicits applications from research partnerships between academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that address important biomedical problems. The objectives are to establish these technologies as robust, well-characterized solutions that fulfill unmet needs and enhance understanding of life science processes or medical practice. Awards will support multidisciplinary teams applying an integrative, quantitative bioengineering approach to develop innovations that can deliver new capabilities within 5-10 years.

The funding opportunity is sponsored by the Department of Health and Human Services' National Institutes of Health. It is assigned to several NIH grant programs, including Cancer Detection and Diagnosis Research, Cancer Treatment Research, Discovery and Applied Research for Technological Innovations to Improve Human Health, Aging Research, and Vision Research. Eligible applicants include higher education institutions, small businesses, non-profits, and state/local governments.